Correction: Functional magnetic resonance: biomarkers of response in breast cancer by O'Flynn, Elizabeth AM & deSouza, Nandita M
Upon publication of our article [1], we noticed that the 
wrong image had been uploaded for Figure 6a. Th  e  ﬁ  gure 
as it should appear can be found below.
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Figure 6. T2*W images of a breast tumour. (a-c) Sagittal T2W (a), dynamic contrast-enhanced (DCE) subtracted image at time point 2.44 minutes 
(b), and T2*W image (c) in a patient with a palpable breast lump in the upper outer quadrant. The tumour seen in (a) and highlighted in (b) shows 
heterogeneity of T2* with faster signal decay in the inferior part of the tumour, indicating a greater deoxyhaemoglobin content here.
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